Efficacy of bupropion in the indigenous Maori population in New Zealand.
about
Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.Effectiveness of smoking cessation therapies: a systematic review and meta-analysisAntidepressants for smoking cessationInterventions for preventing weight gain after smoking cessationInterventions for smoking cessation in Indigenous populationsAntidepressants for smoking cessationEffective strategies to reduce commercial tobacco use in Indigenous communities globally: A systematic reviewPharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.Using breath carbon monoxide to validate self-reported tobacco smoking in remote Australian Indigenous communities.Smoking cessation in indigenous populations of Australia, New Zealand, Canada, and the United States: elements of effective interventions.An innovative team-based stop smoking competition among Māori and Pacific Island smokers: rationale and method for the study and its evaluation.What potential has tobacco control for reducing health inequalities? The New Zealand situation.Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?When There Is Not Enough Evidence and When Evidence Is Not Enough: An Australian Indigenous Smoking Policy Study.The Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote aboriginal Australian health care setting.A systematic review of barriers and facilitators to participation in randomized controlled trials by Indigenous people from New Zealand, Australia, Canada and the United States.The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.
P2860
Q21093272-B1EE2368-F3A3-4601-A854-07C99032EC9AQ21093304-2DBF17F8-3DFD-4419-9D12-5342296B5203Q24201167-B456EF7A-E5F0-4421-81F2-8E2FD3439FFAQ24203883-29F3A4FB-807A-48C2-8190-290D5CA9D2FEQ24203897-E3A7EC53-8E56-41D6-B0E5-3FF961DDB937Q24246426-314FE3F3-2975-4EA9-99D8-F62AB0FE126BQ26769672-9CB9F6A1-5288-4C29-BA5A-5CA53E74EBA8Q33351611-851B54EB-3E61-4788-B573-7A96CB659296Q33705558-945F4141-70D4-42F1-8872-EF8D0A74F3B1Q34885527-C91B75CB-76D1-431B-AEB3-9803C2CF65FFQ35074722-034A05D8-E87E-4D36-85F5-F1E709EC75ABQ35157484-0E0D026D-13FE-4E13-BC3B-DE461520B0BAQ37000723-25AD0282-6B32-4F1D-AE80-BE7103B59E12Q37352005-CA824B64-21FC-46CA-9E28-D139F6C28F85Q37528280-2913F92C-F191-4B69-A407-A390B4C25CD9Q38213000-AD484B3F-06DD-4EF7-A159-A9DEA32671E9Q47989082-CD41AFDB-8F5A-42E5-8CC9-A14C7E7838C9
P2860
Efficacy of bupropion in the indigenous Maori population in New Zealand.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy of bupropion in the indigenous Maori population in New Zealand.
@ast
Efficacy of bupropion in the indigenous Maori population in New Zealand.
@en
type
label
Efficacy of bupropion in the indigenous Maori population in New Zealand.
@ast
Efficacy of bupropion in the indigenous Maori population in New Zealand.
@en
prefLabel
Efficacy of bupropion in the indigenous Maori population in New Zealand.
@ast
Efficacy of bupropion in the indigenous Maori population in New Zealand.
@en
P2093
P2860
P356
P1433
P1476
Efficacy of bupropion in the indigenous Maori population in New Zealand
@en
P2093
Ryder-Lewis S
Timu-Parata C
P2860
P304
P356
10.1136/THX.2004.030239
P407
P577
2005-02-01T00:00:00Z